Correlation Between Agios Pharm and Arvinas
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Arvinas, you can compare the effects of market volatilities on Agios Pharm and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Arvinas.
Diversification Opportunities for Agios Pharm and Arvinas
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Agios and Arvinas is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Agios Pharm i.e., Agios Pharm and Arvinas go up and down completely randomly.
Pair Corralation between Agios Pharm and Arvinas
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.85 times more return on investment than Arvinas. However, Agios Pharm is 1.18 times less risky than Arvinas. It trades about 0.17 of its potential returns per unit of risk. Arvinas is currently generating about 0.04 per unit of risk. If you would invest 4,473 in Agios Pharm on September 2, 2024 and sell it today you would earn a total of 1,466 from holding Agios Pharm or generate 32.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Agios Pharm vs. Arvinas
Performance |
Timeline |
Agios Pharm |
Arvinas |
Agios Pharm and Arvinas Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agios Pharm and Arvinas
The main advantage of trading using opposite Agios Pharm and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |